ArticleJCO precision oncology2025

Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the Breast.

Julia Foldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.